Objective: To evaluate the additive value of Contrast Enhanced Spectral Mammography (CESM) in the preoperative assessment of malignant lesions in dense breast parenchyma regarding multiplicity. Material and methods: The study included 160 women having heterogeneous dense breast parenchyma (ACR c and d) with suspicious lesions identified on sono mammography examination. All patients performed contrast enhanced spectral mammography to confirm or exclude lesion multiplicity. The number of lesions was calculated in the contrast high energy subtraction images with the reference standard being histopathological analysis. Results: Adding CESM to sono-mammography the accuracy in identifying multiple malignant lesion increased from 81.8% accuracy of sono-mammography up to 100% accuracy after adding CESM. Conclusion: Contrast enhanced spectral mammogram showed an added value in the preoperative assessment of breast masses increasing the accuracy of detection of lesions and multiplicity (multifocality and multi-centricity).
Introduction
Breast cancer is one of the most common types of cancer [1] . In dense breasts, the superimposition of different layers of the normal tissue can mimic an architectural distortion or lesion. The superimposition and masking of tissue in the image will contribute to the number of false-positives and false-negatives associated with mammography rendering a proper assessment of multifocality in suspicious breast lesions for preoperative evaluation [2, 3] . Dual-energy CESM presents the ability to gather functional data of breast masses with the merits of rapid acquisition, immediate availability in the mammography unit without a new appointment, very easy and fast interpretation by the radiologists and is well understood by the oncologist and the surgeons [4, 5] .
The purpose of this study is to evaluate the additive value of Contrast Enhanced Spectral Mammography (CESM) in the preoperative assessment of malignant lesions in dense breast parenchyma regarding multiplicity.
Material and methods
The pool of the study included 160/760 patients who performed CESM over a period of 18 months. Patients were selected on the basis of their breast density category; c or d according to the ACR breast density classification. All patients were referred to perform further Contrast Enhanced Spectral Mammography to confirm or exclude lesion multiplicity. The number of lesions was calculated in the contrast high energy subtraction images by two different expert radiologists who were blinded to the sono mammography findings. Regarding contrast-enhanced mammogram the lesions were analyzed by the radiologist for the presence or lack of enhancement, number of enhancing lesions and multifocality/multi-centricity. All cases underwent histo-pathological analysis via core biopsy for initial diagnosis. In accordance with initial pathology reports, all benign lesions (33/160, 20.6%) were excluded. The accuracy of sono-mammography and CESM as regards identification of multiplicity was calculated and compared in the remaining malignant patients (127/160, 79.35%). The reference standard for malignant lesions multiplicity was the histopathological analysis of the post operative surgical specimens.
Results
The pool of the study included 160 female patients with dense breasts out of 760 patients did contrast enhanced mammogram over 18 months. The study population's age range was 20-80 years.
Patients presenting with edematous changes of the breast represented (28.8%,46/160) of all patients (Table 1 ). The number of the benign and malignant cases and detailed pathological diagnosis demonstrated at Tables 2 and 3. Out of 160 patients, 149 patients showed enhancement on CESM representing 93.1% of patients with 11 patients only showing no pathological enhancement representing 6.9% of all patients.
The pathological mass enhancement was elicited in 121 patient (81.2%) while non-mass enhancement in 28 patients (18.8%) (Graph 1) (see Table 4 and 5). 
